Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYANOTECH CORPCYAN · Entity 8431 | CFO, VP, Treasurer, Secretary | July 13, 2018 | July 18, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYANOTECH CORP
Report date July 13, 2018 · Filed July 18, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted stock unitsSEC Table II · derivative / convertible security | Direct | 2,026 |
Reported balance
After 2018-07-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-07-13 · Grant · Acquired 2,026 · Balance 2,026 F1: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2: The restricted stock units shall vest as to 676 shares on July 13, 2019, 675 shares on July 13, 2020 and 675 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. |
| Restricted stock unitsSEC Table II · derivative / convertible security | Direct | 203 |
Reported balance
Holding disclosure · report date 2018-07-13 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 203 F1: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F3: The restricted stock units shall vest as to 101 shares on April 5, 2019 and 102 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. |
| Cyanotech common stockSEC Table I · non-derivative | Direct | 5,101 |
Reported balance
Holding disclosure · report date 2018-07-13 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,101 |
| Cyanotech common stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.82 · Expires 2021-08-28 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2018-07-13 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 40,000 F4: Fully exercisable |
| Cyanotech common stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $5.61 · Expires 2022-08-15 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2018-07-13 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 2,000 F4: Fully exercisable |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock.
F2: The restricted stock units shall vest as to 676 shares on July 13, 2019, 675 shares on July 13, 2020 and 675 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date.
F3: The restricted stock units shall vest as to 101 shares on April 5, 2019 and 102 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date.
F4: Fully exercisable
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 13, 2018 Filed Jul 18, 2018 14:47 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted stock units · Derivative | 2,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-013418 · rdgdoc.xml · derivative · entry 2 Deal Jole Eileen · CIK 0001528404 · CFO, VP, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026 Underlying: Cyanotech common stock · 2,026 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 676 shares on July 13, 2019, 675 shares on July 13, 2020 and 675 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 676 shares on July 13, 2019, 675 shares on July 13, 2020 and 675 shares on July 13, 2021, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 15:01 UTC | CYANOTECH CORP CYAN · Entity 8431 | Disposition to issuerRestricted stock units · Derivative | 101 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006543 · rdgdoc.xml · derivative · entry 2 Deal Jole Eileen · CIK 0001528404 · CFO, VP, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203 Underlying: Cyanotech common stock · 101 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 101 shares on April 5, 2018, 101 shares on April 5, 2019 and 102 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 101 shares on April 5, 2018, 101 shares on April 5, 2019 and 102 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 15:01 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCyanotech common stock | 101 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-006543 · rdgdoc.xml · nonDerivative · entry 1 Deal Jole Eileen · CIK 0001528404 · CFO, VP, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 13:29 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted stock units · Derivative | 304 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-006274 · rdgdoc.xml · derivative · entry 2 Deal Jole Eileen · CIK 0001528404 · CFO, VP, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304 Underlying: Cyanotech common stock · 304 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech common stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 101 shares on April 5, 2018, 101 shares on April 5, 2019 and 102 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 101 shares on April 5, 2018, 101 shares on April 5, 2019 and 102 shares on April 5, 2020, in each case subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.